Hao Wang, Zhengxin Dong, Jingyi Shi, Lei Chen, Tao Sun, Weiwen Zhang
{"title":"大肠杆菌中功能性 TadA 变体诱导的全基因组 A 到 G 和 C 到 T 突变","authors":"Hao Wang, Zhengxin Dong, Jingyi Shi, Lei Chen, Tao Sun, Weiwen Zhang","doi":"10.1101/2024.08.29.610230","DOIUrl":null,"url":null,"abstract":"The fusion expression of DNA replication-related proteins with nucleotide deaminase enzymes promotes random mutations in bacterial genomes, thereby increasing genetic diversity. However, most previous studies have focused on cytosine deaminase, which only produces C to T mutations, significantly limiting the variety of mutation types. In this study, we developed a fusion expression system in Escherichia coli by combining DnaG (RNA primase) with adenine deaminase TadA-8e (DnaG-TadA), which rapidly introduced A to G mutations into the E. coli genome, resulting in a 664-fold increase in mutation rate. Additionally, we engineered a dual-functional TadA variant, TadAD, and fused it with DnaG. This construct introduced both C to T and A to G mutations into the genome, with the mutation rate further increased by 370-fold upon co-expression with an uracil glycosylase inhibitor (DnaG-TadAD-UGI). We applied DnaG-TadA and DnaG-TadAD-UGI to adaptive laboratory evolution for Cd2+ and kanamycin resistance, achieving an 8.0 mM Cd2+ and 200 ug/mL kanamycin tolerance within just 17 days and 132 hours, respectively. Compared to standard evolution methods, the final tolerance levels increased by 320% and 266%, respectively. Our work offers a novel strategy for random mutagenesis in E. coli and potentially other species.","PeriodicalId":501408,"journal":{"name":"bioRxiv - Synthetic Biology","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Genome-wide A to G and C to T Mutations Induced by Functional TadA Variants in Escherichia coli\",\"authors\":\"Hao Wang, Zhengxin Dong, Jingyi Shi, Lei Chen, Tao Sun, Weiwen Zhang\",\"doi\":\"10.1101/2024.08.29.610230\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The fusion expression of DNA replication-related proteins with nucleotide deaminase enzymes promotes random mutations in bacterial genomes, thereby increasing genetic diversity. However, most previous studies have focused on cytosine deaminase, which only produces C to T mutations, significantly limiting the variety of mutation types. In this study, we developed a fusion expression system in Escherichia coli by combining DnaG (RNA primase) with adenine deaminase TadA-8e (DnaG-TadA), which rapidly introduced A to G mutations into the E. coli genome, resulting in a 664-fold increase in mutation rate. Additionally, we engineered a dual-functional TadA variant, TadAD, and fused it with DnaG. This construct introduced both C to T and A to G mutations into the genome, with the mutation rate further increased by 370-fold upon co-expression with an uracil glycosylase inhibitor (DnaG-TadAD-UGI). We applied DnaG-TadA and DnaG-TadAD-UGI to adaptive laboratory evolution for Cd2+ and kanamycin resistance, achieving an 8.0 mM Cd2+ and 200 ug/mL kanamycin tolerance within just 17 days and 132 hours, respectively. Compared to standard evolution methods, the final tolerance levels increased by 320% and 266%, respectively. Our work offers a novel strategy for random mutagenesis in E. coli and potentially other species.\",\"PeriodicalId\":501408,\"journal\":{\"name\":\"bioRxiv - Synthetic Biology\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"bioRxiv - Synthetic Biology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.08.29.610230\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"bioRxiv - Synthetic Biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.08.29.610230","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
DNA 复制相关蛋白与核苷酸脱氨酶的融合表达促进了细菌基因组的随机突变,从而增加了遗传多样性。然而,以往的研究大多集中在胞嘧啶脱氨酶上,它只能产生 C 到 T 的突变,大大限制了突变类型的多样性。在这项研究中,我们在大肠杆菌中开发了一种融合表达系统,将 DnaG(RNA 引物酶)与腺嘌呤脱氨酶 TadA-8e (DnaG-TadA)结合在一起,迅速将 A 到 G 的突变引入大肠杆菌基因组,使突变率提高了 664 倍。此外,我们还设计了一种双功能 TadA 变体 TadAD,并将其与 DnaG 融合。这种构建体在基因组中引入了 C 到 T 和 A 到 G 的突变,在与尿嘧啶糖基化酶抑制剂(DnaG-TadAD-UGI)共同表达时,突变率进一步增加了 370 倍。我们将 DnaG-TadA 和 DnaG-TadAD-UGI 应用于实验室对 Cd2+ 和卡那霉素抗性的适应性进化,分别在 17 天和 132 小时内实现了对 8.0 mM Cd2+ 和 200 ug/mL 卡那霉素的耐受性。与标准进化方法相比,最终耐受水平分别提高了 320% 和 266%。我们的工作为大肠杆菌及其他潜在物种的随机诱变提供了一种新策略。
Genome-wide A to G and C to T Mutations Induced by Functional TadA Variants in Escherichia coli
The fusion expression of DNA replication-related proteins with nucleotide deaminase enzymes promotes random mutations in bacterial genomes, thereby increasing genetic diversity. However, most previous studies have focused on cytosine deaminase, which only produces C to T mutations, significantly limiting the variety of mutation types. In this study, we developed a fusion expression system in Escherichia coli by combining DnaG (RNA primase) with adenine deaminase TadA-8e (DnaG-TadA), which rapidly introduced A to G mutations into the E. coli genome, resulting in a 664-fold increase in mutation rate. Additionally, we engineered a dual-functional TadA variant, TadAD, and fused it with DnaG. This construct introduced both C to T and A to G mutations into the genome, with the mutation rate further increased by 370-fold upon co-expression with an uracil glycosylase inhibitor (DnaG-TadAD-UGI). We applied DnaG-TadA and DnaG-TadAD-UGI to adaptive laboratory evolution for Cd2+ and kanamycin resistance, achieving an 8.0 mM Cd2+ and 200 ug/mL kanamycin tolerance within just 17 days and 132 hours, respectively. Compared to standard evolution methods, the final tolerance levels increased by 320% and 266%, respectively. Our work offers a novel strategy for random mutagenesis in E. coli and potentially other species.